US 8785393
Ophthalmic pharmaceutical compositions of DP2 receptor antagonists
granted A61KA61K31/435A61K31/4355
Quick answer
US patent 8785393 (Ophthalmic pharmaceutical compositions of DP2 receptor antagonists) held by Panmira Pharmaceuticals, LLC expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Panmira Pharmaceuticals, LLC
- Grant date
- Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/435, A61K31/4355, A61K31/4418, A61P